Search Result "PTEN phosphorylation"
PTEN, Insulin Resistance and Cancer
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 25 Year: 2017 Page: 3667-3676
Author(s): Aiqing Li,Minzi Qiu,Hongbo Zhou,Tao Wang,Wen Guo
Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 5 Year: 2011 Page: 536-547
Author(s): G. Singh, A. M. Chan
The Protein-Protein Interaction-Mediated Inactivation of PTEN
Journal: Current Molecular Medicine
Volume: 14 Issue: 1 Year: 2014 Page: 22-33
Author(s): J. De Melo,L. He,D. Tang
Therapeutic Targeting of Cancers with Loss of PTEN Function
Journal: Current Drug Targets
Volume: 15 Issue: 1 Year: 2014 Page: 65-79
Author(s): Lloye M. Dillon,Todd W. Miller
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 187-198
Author(s): Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link, Juan F.M. Leal
PI-3 Kinase-PTEN Signaling Node: An Intercept Point for the Control of Angiogenesis
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 4 Year: 2009 Page: 380-388
Author(s): R. C. Castellino, C. R. Muh, D. L. Durden
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia
Journal: Current Drug Targets
Volume: 18 Issue: 4 Year: 2017 Page: 389-395
Author(s): Alessandro Morotti,Davide Torti,Giovanna Carra,Cristina Panuzzo,Sabrina Crivellaro,Riccardo Taulli,Carmen Fava,Angelo Guerrasio,Giuseppe Saglio
Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 9 Year: 2015 Page: 1185-1189
Author(s): Shi-zheng Li,Shi-feng Qiao,Jun-hua Zhang,Kun Li
Cilostazol: Therapeutic Potential Against Focal Cerebral Ischemic Damage
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 5 Year: 2006 Page: 565-573
Author(s): Ki W. Hong, Jeong H. Lee, Ki Y. Kim, So Y. Park, Won S. Lee
Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 1 Year: 2021 Page: 108-119
Author(s): Shadi Esmaeili,Ava Safaroghli-Azar,Atieh Pourbagheri-Sigaroodi,Sina Salari,Ahmad Gharehbaghian,Mohsen Hamidpour,Davood Bashash